Almac’s Clinical Services is introducing enhanced containment equipment and processes for dispensing and bottling solid-dosage products at its EU and U.S. headquarters. The Almac Group offers services ranging from R&D, biomarker discovery and development, API manufacture, formulation development, clinical trial supply and IXRS technology to commercial-scale manufacture.
Almac is expanding its commercial manufacturing, thanks to a total investment of £13.7million, which includes some financial support from Invest Northern Ireland. Expansions at its Craigavon, Northern Ireland, site include a new non-GMP drug development facility as well as the creation of a new 13,400-sq-ft formulation development facility and analytical laboratories. Over the next three years, up to 229 jobs will be created, Almac reported in a press release.
SteriPack USA, which opened its first U.S. medical packaging converting facility in Lakeland, FL, last year, has received the “Governor’s Business Ambassador Award” from Florida Governor Rick Scott.
SteriPack USA was recognized for "exceeding commitments in job creation," the company reported in a press release, and it "will seek further employment in the near future."
In many instances, contract packagers (aka outsourcing service providers) have invested in specific technologies or capabilities to be able to provide their pharmaceutical and medical device customers with a competitive edge.
Indianapolis-based contract manufacturer Redbird Medical is launching assembly, packaging, and supply chain management services for life sciences companies. Founded in 2012 as an affiliate company of The Phoenix Group, Redbird Medical can manage the supply chain through supplier qualification and monitoring, procurement, verification of incoming materials, and inventory management.
Brad Carlson has joined Aenova, a provider of development and manufacturing services for medicines and dietary supplements, as its new vice president of marketing & sales for the Americas. Carlson has spent more than 20 years in the life science industry.
Northwest Biotherapeutics, Inc. (OTC.BB: NWBO) (the "Company" or "Northwest Bio") announced today that its partner in Germany, Fraunhofer IZI, has received the official approval and certification from the regional and national regulatory agencies in Germany (including the Paul-Ehrlich-Institut, or PEI – the German equivalent of the U.S. FDA) for the manufacture of Northwest Bio's DCVax-L immune therapy for human patients with Glioblastoma multiforme brain cancer.
Three managers from B. Braun Medical Inc. will discuss risk mitigation in contract manufacturing of medical devices at the 2012 Medical Design & Manufacturing (MD&M) East conference, May 21-24 in Philadelphia. The May 24 panel discussion, entitled “Best Practices for Risk Mitigation in Outsourced Manufacturing,” will feature Thomas Black, Vice President, OEM and International Divisions Sales and Marketing; Mike Bartholomew, Director, Purchased Finished Goods; and Kimberly Paris, Vice President of Quality Operations.
Pharma Tech Industries (PTI) has been selected as the Best Overall Supplier by one of the world’s five largest pharmaceutical companies. A pharmaceutical contract manufacturer and packager of powder products, PTI is one of 67 contract manufacturing organizations in the company’s supplier network.
Tapemark has agreed to acquire the iontoPatch business from Travanti Pharma Inc., a wholly owned subsidiary of Teikoku Pharma USA Inc. The iontoPatch product line along with iontophoretic technology for use in medical devices and cosmetics will be marketed under the Travanti Medical name.